The Cigna Group (NYSE:CI) Holdings Trimmed by South Dakota Investment Council

South Dakota Investment Council lowered its position in shares of The Cigna Group (NYSE:CI) by 22.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,906 shares of the health services provider’s stock after selling 1,702 shares during the quarter. South Dakota Investment Council’s holdings in The Cigna Group were worth $1,769,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Parnassus Investments LLC acquired a new position in shares of The Cigna Group during the 3rd quarter valued at about $731,041,000. FMR LLC increased its holdings in shares of The Cigna Group by 13.8% during the 3rd quarter. FMR LLC now owns 15,967,363 shares of the health services provider’s stock valued at $4,567,783,000 after acquiring an additional 1,939,554 shares during the last quarter. Cerity Partners LLC increased its holdings in shares of The Cigna Group by 1,039.4% during the 4th quarter. Cerity Partners LLC now owns 590,063 shares of the health services provider’s stock valued at $176,694,000 after acquiring an additional 538,274 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in The Cigna Group by 3.0% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 11,833,753 shares of the health services provider’s stock valued at $3,385,282,000 after buying an additional 345,605 shares during the last quarter. Finally, Jennison Associates LLC grew its holdings in The Cigna Group by 127.3% in the 4th quarter. Jennison Associates LLC now owns 566,233 shares of the health services provider’s stock valued at $169,558,000 after buying an additional 317,081 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Stock Down 0.1 %

Shares of The Cigna Group stock opened at $352.27 on Thursday. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.61. The Cigna Group has a 12 month low of $240.50 and a 12 month high of $365.71. The business has a fifty day simple moving average of $349.31 and a 200 day simple moving average of $317.09. The stock has a market cap of $102.99 billion, a PE ratio of 20.26, a price-to-earnings-growth ratio of 1.08 and a beta of 0.56.

The Cigna Group (NYSE:CI) last posted its earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.54 by $0.25. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The firm had revenue of $51.15 billion during the quarter, compared to analysts’ expectations of $48.91 billion. During the same period in the previous year, the firm earned $4.96 earnings per share. The company’s revenue was up 11.8% on a year-over-year basis. Research analysts predict that The Cigna Group will post 28.36 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th will be paid a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.59%. The Cigna Group’s payout ratio is 32.20%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CI shares. StockNews.com raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Thursday, March 14th. Cantor Fitzgerald reissued an “overweight” rating and set a $384.00 price objective on shares of The Cigna Group in a report on Wednesday, April 10th. Morgan Stanley restated an “overweight” rating and set a $392.00 target price (up previously from $382.00) on shares of The Cigna Group in a research report on Monday, March 4th. Deutsche Bank Aktiengesellschaft upgraded The Cigna Group from a “hold” rating to a “buy” rating and raised their target price for the stock from $355.00 to $370.00 in a research report on Thursday, February 1st. Finally, Sanford C. Bernstein upgraded The Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $330.00 to $372.00 in a research report on Thursday, January 4th. Two research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $362.14.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 31,209 shares of the business’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $355.17, for a total value of $11,084,500.53. Following the completion of the transaction, the chief executive officer now directly owns 348,054 shares of the company’s stock, valued at $123,618,339.18. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CEO David Cordani sold 31,209 shares of the business’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $355.17, for a total value of $11,084,500.53. Following the sale, the chief executive officer now directly owns 348,054 shares in the company, valued at $123,618,339.18. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Eric P. Palmer sold 6,083 shares of the business’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $340.00, for a total value of $2,068,220.00. Following the completion of the sale, the insider now owns 44,649 shares in the company, valued at $15,180,660. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 114,144 shares of company stock valued at $39,296,330. Company insiders own 0.60% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.